text_1: Medtronic atrial fibrillation system shines in study
text_2: This story reports on results from a preliminary study for a device in development to treat atrial fibrillation. Although it appears to be intended as a business story, we think shareholders would care about cost and comparisons with existing alternatives as much as patients and consumers should care about these. Since the story acknowledged that a competing device was already on the market, it wouldn’t have required much more work to do some comparative analysis – especially if our call for an independent expert’s perspective was heeded.